Relationship of kidney function estimates to risk improves by measuring cystatin C in the blood
9/09/2013
A new, international study from the Chronic Kidney Disease Prognosis Consortium found that use of blood levels of cystatin C to estimate kidney function - alone or in combination with creatinine - strengthens the association between kidney function and risks of death and end-stage renal disease...
MRI right before or after surgery does not benefit women with early breast cancer
9/08/2013
Memorial Sloan-Kettering Cancer Center study shows that the use of MRI before or immediately after surgery in women with DCIS was not associated with reduced local recurrence or contralateral breast cancer rates. The findings are being presented on Saturday, September 7, 2013, at the 2013 Breast Cancer Symposium...
Cancer may get help from immune cells
9/07/2013
A new study from the University of Michigan (UM) suggests a group of immune cells, known as myeloid derived suppressor cells, could be giving cancer a hand by bolstering cancer stem cells - the small number of cells within a tumor that drive its growth. The researchers report their work in the September 4th online issue of the journal Immunity...
Canadian group gives guideline recommendations for lung cancer screening
9/07/2013
Lung cancer is the most common cause of cancer death in Ontario. Screening for lung cancer using low-dose computed tomography (LDCT) has been the subject of many research studies since the 1990s...
Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the treatment...
Cancer may get help from immune cells
9/07/2013
A new study from the University of Michigan (UM) suggests a group of immune cells, known as myeloid derived suppressor cells, could be giving cancer a hand by bolstering cancer stem cells - the small number of cells within a tumor that drive its growth. The researchers report their work in the September 4th online issue of the journal Immunity...
Lung cancer, COPD cases to rise over next decades
9/06/2013
A new report issued from the European Respiratory Society (ERS) reveals that conditions of the lung cause 1 in 10 deaths in Europe, with mortality as a result of lung cancer and chronic obstructive pulmonary disease (COPD) expected to rise in the future...
ARIAD reaches 50 percent patient enrollment in Phase 3 EPIC trial of Iclusig
9/06/2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) has announced enrollment of fifty percent of the patients planned in its randomized Phase 3 trial of Iclusig® (ponatinib) in adult patients with newly diagnosed chronic myeloid leukemia (CML)...
ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company focusing on rationally designed therapeutic vaccines against cancer and persistent viral infections, has announced the publication of a peer-reviewed paper in the European Journal of Immunology...
Chemotherapy helps elderly patients with small cell lung cancer
9/06/2013
Although numerous randomized clinical trials have demonstrated a benefit of chemotherapy for patients with small-cell lung cancer (SCLC), these trials have predominantly compared different chemotherapy regimens rather than comparing chemotherapy to best supportive care. Some of them included chest radiation or prophylactic cranial irradiation. Moreover, many trials excluded elderly patients...